As of 2025-05-27, the Gross Margin of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is 91.1%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 91.1% |
2023-12-31 | 91.3% |
2022-12-31 | 91.6% |
2021-12-31 | 92.9% |
2020-12-31 | 92.3% |
2019-12-31 | 92.5% |
2018-12-31 | 90.4% |
2017-12-31 | 90.4% |
- | |
- |